2024 Buick Encore GX Avenir
1.3 L • I3 • FWD • AT
KL4AMFSLXRB056946
Sales history: 1
• $5,400Highlights
Condition
Run and drive
Seller
Insurance • State Farm Insurance
Key included
Yes
Docs
Bad
History
1 record
Drive
1.3 L • I3 • FWD • AT
Odometer
12,870 mi ≈ 20,712 km
Primary damage
Rear end
Docs
MI • Scrap Cert
Extra
Auction
VIN
KL4AMFSLXRB056946
Lot number
91343785Copart
Sale status
On approval
Seller type
Insurance
Seller
State Farm Insurance
Location
Lansing, MI
Description
Fuel type
Gasoline
Body color
Black
Body type
SUV
Trim
Avenir
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Buick models
2024 Buick Encore GX Avenir • 1.3 L • I3 • FWD • Automatic • Copart Lot: 91343785 • VIN: KL4AMFSLXRB056946
Find out more about this 2024 Buick Encore GX Avenir, available at the Copart salvage car auction as lot 91343785 in Lansing, MI. This car has Rear end main damage. It is listed with Run and drive start condition code. Odometer shows 12,870 mi. This Black Buick Encore GX SUV is equipped with Gasoline 1.3 L engine, FWD drivetrain, Automatic transmission. Check the vehicle history report for KL4AMFSLXRB056946 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
